SANA - Sana Biotechnology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.67
DETAILS
HIGH:
$12.00
LOW:
$7.00
MEDIAN:
$7.00
CONSENSUS:
$8.67
UPSIDE:
182.41%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 12.8 | 0 | 0 | 0 | 0 | 10.2 | 3.9 | 0.0 |
| Gross Profit | (12.8) | 0 | 0 | 0 | 0 | (10.2) | (3.9) | (0.0) |
| Operating Expenses | ||||||||
| R&D Expenses | 132.0 | 208.7 | 219.8 | 201.0 | 306.5 | 122.7 | 119.4 | 4.0 |
| SG&A Expenses | 44.3 | 64.0 | 73.3 | 71.6 | 50.4 | 28.3 | 21.8 | 4.2 |
| Other Expenses | 1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 178.2 | 272.7 | 293.1 | 272.6 | 356.9 | 151.0 | 141.2 | 8.2 |
| Operating Income | ||||||||
| Operating Income | (191.0) | (272.7) | (293.1) | (272.6) | (356.9) | (161.1) | (141.2) | (8.2) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 3.8 | 10.5 | 9.9 | 3.8 | 0.7 | 0.7 | 2.9 | 0 |
| Profitability | ||||||||
| EBITDA | (178.2) | (255.3) | (268.6) | (256.9) | (345.8) | (287.0) | (138.9) | (13.2) |
| EBIT | (191.0) | (272.7) | (293.1) | (272.6) | (356.9) | (297.2) | (142.8) | (13.2) |
| Income Before Tax | (244.2) | (266.8) | (283.3) | (269.5) | (355.9) | (297.2) | (138.3) | (13.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | (11.9) | (7.5) | 0 |
| Net Income | (244.2) | (266.8) | (283.3) | (269.5) | (355.9) | (285.3) | (130.8) | (13.2) |
| Per Share Data | ||||||||
| EPS (Basic) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| EPS (Diluted) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| Shares Outstanding | 253.2 | 230.9 | 194.5 | 188.3 | 166.4 | 187.5 | 187.3 | 187.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 71.9 | 127.6 | 133.5 | 176.8 | 253.0 | 124.8 | 80.0 | 30.6 |
| Short-Term Investments | 66.5 | 24.9 | 71.7 | 247.2 | 298.0 | 253.5 | 59.0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.3 | 8.3 | 8.3 | 20.5 | 0 | 0 | 0 | 0 |
| Total Current Assets | 148.7 | 160.8 | 213.5 | 444.4 | 558.1 | 384.5 | 144.3 | 32.6 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 65.2 | 135.3 | 145.6 | 159.4 | 161.8 | 109.9 | 68.8 | 0.6 |
| Goodwill | 140.6 | 140.6 | 140.6 | 140.6 | 140.6 | 140.6 | 140.6 | 0 |
| Intangible Assets | 59.2 | 59.2 | 59.2 | 59.2 | 59.2 | 59.2 | 59.2 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 10.1 | 195.9 | 33.7 | 0 | 0.8 |
| Other Non-Current Assets | 3.2 | 5.1 | 6.4 | 9.0 | 13.8 | 2.3 | 2.3 | 0.3 |
| Total Non-Current Assets | 268.2 | 340.2 | 351.8 | 378.3 | 571.3 | 345.8 | 270.9 | 1.7 |
| Total Assets | 416.9 | 501.0 | 565.3 | 822.7 | 1,129.4 | 730.3 | 415.2 | 34.3 |
| Current Liabilities | ||||||||
| Account Payables | 1.7 | 5.2 | 4.1 | 2.9 | 2.2 | 2.3 | 0 | 0.3 |
| Short-Term Debt | 14.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 62.1 | 0.3 | 23.5 | 76.6 | 74.6 | 14.0 | 8.1 | 0.7 |
| Total Current Liabilities | 78.7 | 45.4 | 64.5 | 111.5 | 99.2 | 31.5 | 19.3 | 1.8 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 113.4 | 123.4 | 122.4 | 116.0 | 199.9 | 1,051.8 | 492.1 | 45.7 |
| Total Non-Current Liabilities | 177.3 | 205.1 | 213.3 | 211.9 | 301.7 | 1,120.0 | 538.4 | 45.7 |
| Total Liabilities | 256.0 | 250.5 | 277.8 | 323.4 | 400.9 | 1,151.5 | 557.7 | 47.5 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,849.0) | (1,604.8) | (1,338.1) | (1,054.8) | (785.4) | (429.4) | (144.1) | (13.2) |
| Accumulated Other Comprehensive Income | 0.0 | 0.0 | (0.1) | (4.3) | (1.4) | 0.0 | 0.0 | (45.7) |
| Total Stockholders' Equity | 160.9 | 250.5 | 287.5 | 499.3 | 728.5 | (421.2) | (142.5) | (13.2) |
| Total Liabilities & Equity | 416.9 | 501.0 | 565.3 | 822.7 | 1,129.4 | 730.3 | 415.2 | 34.3 |
| Debt Metrics | ||||||||
| Total Debt | 78.9 | 94.2 | 104.1 | 108.3 | 110.9 | 71.9 | 47.7 | 0 |
| Net Debt | 7.0 | (33.4) | (29.4) | (68.5) | (142.1) | (52.9) | (32.3) | (30.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (244.2) | (266.8) | (283.3) | (269.5) | (355.9) | (285.3) | (130.8) | (13.2) |
| Depreciation & Amortization | 12.8 | 17.4 | 24.6 | 15.6 | 11.1 | 5.9 | 1.8 | 0.0 |
| Stock-Based Compensation | 25.5 | 37.7 | 35.5 | 38.3 | 22.4 | 5.8 | 1.5 | 0.1 |
| Change in Working Capital | (10.1) | (1.2) | 18.6 | 7.5 | 9.8 | 6.2 | 10.5 | (0.3) |
| Other Non-Cash Items | 72.2 | (10.3) | (49.0) | (82.1) | 61.6 | 129.4 | 39.0 | (0.2) |
| Operating Cash Flow | (143.8) | (223.2) | (253.6) | (290.1) | (251.1) | (138.0) | (85.5) | (13.5) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.9) | (33.4) | (20.0) | (20.9) | (29.9) | (23.9) | (26.2) | (0.5) |
| Acquisitions | 1.4 | 0 | (0.2) | (0.2) | 0 | 0 | (3.2) | 0 |
| Purchases of Investments | (87.3) | 0 | (157.7) | (78.7) | (491.4) | (387.4) | (141.5) | 0 |
| Sales/Maturities of Investments | 46.6 | 0 | 349.8 | 310.1 | 280.0 | 158.7 | 83.0 | 0 |
| Other Investing Activities | 0 | 17.5 | 0.2 | 0.2 | (4.6) | 0 | 0.1 | (0.3) |
| Investing Cash Flow | (40.2) | 17.5 | 172.0 | 210.6 | (245.8) | (252.6) | (87.9) | (0.8) |
| Financing Activities | ||||||||
| Net Debt Issuance | (0.3) | 7.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 11.0 | 0 | 0 | 0 | 0.1 | (0.0) | 0 |
| Financing Cash Flow | 128.7 | 199.7 | 31.6 | 4.9 | 631.8 | 435.7 | 223.7 | 45.7 |
| Cash Position | ||||||||
| Net Change in Cash | (55.3) | (6.0) | (49.9) | (74.6) | 134.9 | 45.1 | 50.4 | 31.4 |
| Cash at Beginning | 131.4 | 137.3 | 187.3 | 261.8 | 126.9 | 81.8 | 31.4 | (0.8) |
| Cash at End | 76.1 | 131.4 | 137.3 | 187.3 | 261.8 | 126.9 | 81.8 | 30.6 |
| Free Cash Flow | (144.8) | (256.6) | (273.6) | (310.9) | (280.9) | (161.9) | (111.7) | (14.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (12.8) | 0 | 0 | 0 | 0 | (10.2) | (3.9) | (0.0) |
| Operating Income | (191.0) | (272.7) | (293.1) | (272.6) | (356.9) | (161.1) | (141.2) | (8.2) |
| Net Income | (244.2) | (266.8) | (283.3) | (269.5) | (355.9) | (285.3) | (130.8) | (13.2) |
| EPS (Diluted) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 71.9 | 127.6 | 133.5 | 176.8 | 253.0 | 124.8 | 80.0 | 30.6 |
| Total Assets | 416.9 | 501.0 | 565.3 | 822.7 | 1,129.4 | 730.3 | 415.2 | 34.3 |
| Total Debt | 78.9 | 94.2 | 104.1 | 108.3 | 110.9 | 71.9 | 47.7 | 0 |
| Stockholders' Equity | 160.9 | 250.5 | 287.5 | 499.3 | 728.5 | (421.2) | (142.5) | (13.2) |
| Cash Flow | ||||||||
| Operating Cash Flow | (143.8) | (223.2) | (253.6) | (290.1) | (251.1) | (138.0) | (85.5) | (13.5) |
| Capital Expenditure | (0.9) | (33.4) | (20.0) | (20.9) | (29.9) | (23.9) | (26.2) | (0.5) |
| Free Cash Flow | (144.8) | (256.6) | (273.6) | (310.9) | (280.9) | (161.9) | (111.7) | (14.0) |